View in EDS HTML Full Text PDF Full Text

Regorafenib as a potential drug for severe COVID-19: inhibition of inflammasome activation in mice.

Saved in:
Bibliographic Details
Title: Regorafenib as a potential drug for severe COVID-19: inhibition of inflammasome activation in mice.
Authors: Jeong JH; Department of Microbiology, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea., Kim SO; Department of Biochemistry, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea., Min SC; Department of Microbiology, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea., Kim EG; Department of Biochemistry, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea., Song MS; Department of Microbiology, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea., Shin EY; Department of Biochemistry, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea.
Source: FEBS open bio [FEBS Open Bio] 2025 Mar; Vol. 15 (3), pp. 427-435. Date of Electronic Publication: 2025 Feb 03.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons Ltd Country of Publication: England NLM ID: 101580716 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-5463 (Electronic) Linking ISSN: 22115463 NLM ISO Abbreviation: FEBS Open Bio Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39895416
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Regorafenib as a potential drug for severe COVID-19: inhibition of inflammasome activation in mice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jeong+JH%22">Jeong JH</searchLink>; Department of Microbiology, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+SO%22">Kim SO</searchLink>; Department of Biochemistry, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Min+SC%22">Min SC</searchLink>; Department of Microbiology, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+EG%22">Kim EG</searchLink>; Department of Biochemistry, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Song+MS%22">Song MS</searchLink>; Department of Microbiology, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Shin+EY%22">Shin EY</searchLink>; Department of Biochemistry, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101580716%22">FEBS open bio</searchLink> [FEBS Open Bio] 2025 Mar; Vol. 15 (3), pp. 427-435. <i>Date of Electronic Publication: </i>2025 Feb 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons+Ltd%22">John Wiley & Sons Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101580716 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2211-5463 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222115463%22">22115463 </searchLink><i>NLM ISO Abbreviation: </i>FEBS Open Bio <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39895416
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/2211-5463.70002
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 427
    Titles:
      – TitleFull: Regorafenib as a potential drug for severe COVID-19: inhibition of inflammasome activation in mice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jeong JH
      – PersonEntity:
          Name:
            NameFull: Kim SO
      – PersonEntity:
          Name:
            NameFull: Min SC
      – PersonEntity:
          Name:
            NameFull: Kim EG
      – PersonEntity:
          Name:
            NameFull: Song MS
      – PersonEntity:
          Name:
            NameFull: Shin EY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2025 Mar
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2211-5463
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: FEBS open bio
              Type: main
ResultId 1